As we welcome 2025, we'd like to recognize DELFI's incredible team, our valued partners, collaborators and community of supporters. Your tireless efforts in #cancerdetection meaningfully improve patient outcomes. Here's to a bright, healthy #NewYears2025 🎆

DELFI is pleased to announce that we will speak at the upcoming 43rd Annual J.P. Morgan Healthcare Conference next week. Our CEO @Susantousi is scheduled to present on Thursday, January 16, 2025 at 7:30am PT. Read more: prnewswire.com/news-releases/… #JPM2025

Listen to Dr. Ali Zaidi from AHN on the Medical Frontiers podcast as he discusses advances in #liquidbiopsy tech for #cancerscreening, including DELFI’s FirstLook Lung Test blood test, which is available to eligible patients at AHN clinics and screening events.

Read DeciBio's Women of Precision Medicine: 25 Perspectives for 2025, featuring DELFI CEO Susan Tousi and 24 other women leaders driving significant advances in #precisionmedicine. decibio.com/insights/women…

A great new piece in Observer-Reporter highlights DELFI’s collaboration with AHN to offer the FirstLook Lung Test blood test through their primary care, pulmonology, and community-based cancer screening clinics to increase #lungcancerscreening rates. observer-reporter.com/living/health_…

Attending the 43rd Annual J.P. Morgan Healthcare Conference? Don’t miss our CEO Susan Tousi's presentation and Q&A session today at 7:30am PT.

We’re committed to advancing #healthequity by making #cancerscreening accessible. Honoring Dr. King’s legacy means addressing disparities and striving for a future where everyone has access to life-saving technologies. Learn more: delfidiagnostics.com/our-mission/ #MLKDay

Big strides have been made with #lungcancer screening in recent decades, thanks to advancements in science & technology. #LDCT, #AI, #machinelearning & #NGS are transforming early detection. Learn about DELFI’s blood-based FirstLook Lung Test test: delfidiagnostics.com/healthsystems/

Watch this Channel 11 WPXI segment featuring Dr. James Solava, PCP at AHN, explaining how the FirstLook Lung Test blood test makes the process of starting lung cancer screening easier and Mary Knight, an AHN patient, who describes her experience receiving the test.

DELFI Founder Dr. Victor Velculescu will be honored with the Pioneer Award at #PMWC25! Listen to his keynote, “Early Detection of Cancer Using Cell-free DNA Fragmentomes.” Feb 6, 9 am PT | Silicon Valley bit.ly/40xzBOu #CancerResearch #Fragmentomics

"At DELFI Diagnostics, we're focused on addressing the global burden of late-stage cancer diagnosis." — Dr. Lindsey Cotton On #WorldCancerDay, we recognize the need for accessible screening, particularly for #lungcancer, the leading cause of cancer death globally.

Big day for DELFI at #PMWC25 tomorrow! Dr. Victor Velculescu receives the Pioneer Award and delivers his keynote at 9:00 a.m. PT. Later, Peter B. Bach, MD chairs a panel on multi-cancer early detection at 3:30 p.m. PT. Full program: bit.ly/40xzBOu

DELFI CEO Susan Tousi joins @TheralDTimpson on mendelspod to discuss how our next-gen #liquidbiopsy technology makes #lungcancer screening more accessible and shows promise in other cancer types and treatment monitoring. Listen here: mendelspod.com/p/02274357-fc6…

DELFI is proud to endorse the Lung Cancer Screening and Prevention Act (H.R. 1406), introduced to Congress this week by Representative Rep. Vern Buchanan. The bill aims to expedite CMS coverage authority for FDA-approved/cleared #lungcancerscreening tests. buchanan.house.gov/2025/2/buchana…

Lung cancer claims over 127,000 lives annually in the U.S. Early detection aided by tools like FirstLook Lung can help health systems prevent the worst effects of lung cancer. This #NationalCancerPreventionMonth, let’s prioritize lung health. Learn more: delfidiagnostics.com

Join our Becker's Hospital Review webinar on March 18 to learn how healthcare system leaders from OSF HealthCare and AHN are implementing DELFI’s FirstLook Lung Test test for lung cancer screening in their organizations. Register: delfidiagnostics.com/healthsystems/…

DELFI CEO Susan Tousi will be featured in a Plenary Keynote Session at #TRICON2025 tomorrow, March 11 at 4:15 PM PT in San Diego. The panel will explore how innovative companies are pushing the boundaries of precision medicine. Don't miss this discussion! Learn more:

Nicholas Dracopoli, PhD, CSO at DELFI, will be speaking at #TRICON2025 tomorrow, March 12 about DELFI-TF, a tumor-agnostic, mutation-independent WGS test for treatment response monitoring and clinical outcome prediction. If you're attending, don't miss this session:

How are leading health systems implementing AI-powered blood testing for #lungcancerscreening? Find out at the Becker's Hospital Review webinar on March 18 when leaders from OSF HealthCare and AHN share their FirstLook Lung Test implementation strategies. Register: delfidiagnostics.com/healthsystems/…

Just released: Part 2 with DELFI Diagnostics CEO Susan Tousi on the Geonomics Podcast discussing how our advanced genomic technology is revolutionizing lung cancer screening with 75% stage I sensitivity. From engineering to biotech leadership – Susan charts DELFI's vision for